These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12682635)

  • 41. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase.
    Fan S; Ma YX; Wang JA; Yuan RQ; Meng Q; Cao Y; Laterra JJ; Goldberg ID; Rosen EM
    Oncogene; 2000 Apr; 19(18):2212-23. PubMed ID: 10822371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting the pro-survival protein MET with tivantinib (ARQ 197) inhibits growth of multiple myeloma cells.
    Zaman S; Shentu S; Yang J; He J; Orlowski RZ; Stellrecht CM; Gandhi V
    Neoplasia; 2015 Mar; 17(3):289-300. PubMed ID: 25810013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB; Hota C; Wilson SM; Chambers AF
    Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
    Taylor CC
    Endocrinology; 2000 Apr; 141(4):1545-53. PubMed ID: 10746662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.
    Kobayashi E; Sasamura H; Mifune M; Shimizu-Hirota R; Kuroda M; Hayashi M; Saruta T
    Kidney Int; 2003 Oct; 64(4):1179-88. PubMed ID: 12969135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
    Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA; Merlino G
    Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway.
    Ueoka Y; Kato K; Kuriaki Y; Horiuchi S; Terao Y; Nishida J; Ueno H; Wake N
    Br J Cancer; 2000 Feb; 82(4):891-9. PubMed ID: 10732763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor.
    Shima N; Stolz DB; Miyazaki M; Gohda E; Higashio K; Michalopoulos GK
    J Cell Physiol; 1998 Oct; 177(1):130-6. PubMed ID: 9731753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
    Kristensen IB; Christensen JH; Lyng MB; Møller MB; Pedersen L; Rasmussen LM; Ditzel HJ; Abildgaard N
    Br J Haematol; 2013 May; 161(3):373-82. PubMed ID: 23431957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
    Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
    J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway.
    Ueoka Y; Kato K; Wake N
    Mol Cell Endocrinol; 2003 Apr; 202(1-2):81-8. PubMed ID: 12770735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.
    Fornoni A; Li H; Foschi A; Striker GE; Striker LJ
    Am J Pathol; 2001 Jan; 158(1):275-80. PubMed ID: 11141501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway.
    Mildner M; Eckhart L; Lengauer B; Tschachler E
    J Biol Chem; 2002 Apr; 277(16):14146-52. PubMed ID: 11821397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor.
    Klominek J; Baskin B; Liu Z; Hauzenberger D
    Int J Cancer; 1998 Apr; 76(2):240-9. PubMed ID: 9537587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-like growth factor I is a dual effector of multiple myeloma cell growth.
    Ge NL; Rudikoff S
    Blood; 2000 Oct; 96(8):2856-61. PubMed ID: 11023522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
    Asano J; Nakano A; Oda A; Amou H; Hiasa M; Takeuchi K; Miki H; Nakamura S; Harada T; Fujii S; Kagawa K; Endo I; Yata K; Sakai A; Ozaki S; Matsumoto T; Abe M
    Leukemia; 2011 Jul; 25(7):1182-8. PubMed ID: 21475253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.